We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Alcon
ALC
$34.7B
| $11.4M | 0.03% |
+200,000
| New | +$11.8M |
|
|
FSDC
502
DELISTED
FS Development Corp. Class A Common Stock
FSDC
| $11.2M | 0.03% |
+1,000,000
| New | +$10.7M |
|
503
Match Group
MTCH
$8.5B
| $11.1M | 0.03% |
+100,000
| New | +$10.6M |
|
504
Howmet Aerospace
HWM
$114B
| $11M | 0.03% |
656,625
-2,162,682
| -77% | -$36.1M |
|
505
United Airlines
UAL
$42.2B
| $10.9M | 0.03% |
314,309
+30,600
| +11% | +$1.06M |
|
|
HES
506
DELISTED
Hess
HES
| $10.9M | 0.03% |
266,800
-34,900
| -12% | -$1.66M |
|
|
PRVL
507
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $10.9M | 0.03% |
1,071,946
-324,223
| -23% | -$4.35M |
|
|
GSKY
508
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $10.9M | 0.03% |
2,455,140
+1,032,154
| +73% | +$4.91M |
|
|
GTM
509
ZoomInfo Technologies
GTM
$1.2B
| $10.7M | 0.03% |
250,000
-50,000
| -17% | -$1.96M |
|
|
AKUS
510
DELISTED
Akouos Inc
AKUS
| $10.7M | 0.03% |
469,000
-71,000
| -13% | -$1.58M |
|
511
Masco
MAS
$15.3B
| $10.7M | 0.03% |
+193,300
| New | +$10.8M |
|
|
CBAY
512
DELISTED
Cymabay Therapeutics
CBAY
| $10.5M | 0.03% |
1,450,000
-1,050,000
| -42% | -$5.61M |
|
513
Lamb Weston
LW
$7.19B
| $10.5M | 0.03% |
158,000
-5,200
| -3% | -$333K |
|
514
Cboe Global Markets
CBOE
$29.8B
| $10.4M | 0.03% |
119,100
-3,900
| -3% | -$351K |
|
515
Theravance Biopharma
TBPH
$877M
| $10.3M | 0.03% |
700,000
-275,000
| -28% | -$5.15M |
|
516
UDR
UDR
$12.3B
| $10.3M | 0.03% |
317,100
-10,700
| -3% | -$376K |
|
517
Eagle Materials
EXP
$6.55B
| $10.3M | 0.03% |
119,577
-69,623
| -37% | -$5.63M |
|
|
ITCI
518
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $10.3M | 0.03% |
+400,000
| New | +$9.13M |
|
519
MGM Resorts International
MGM
$11.2B
| $10.2M | 0.03% |
470,900
-114,200
| -20% | -$2.26M |
|
520
Dow Inc
DOW
$21.5B
| $10.2M | 0.03% |
+217,100
| New | +$9.75M |
|
521
JB Hunt Transport Services
JBHT
$25.2B
| $10M | 0.03% |
79,400
-3,000
| -4% | -$399K |
|
522
Raymond James Financial
RJF
$34.2B
| $10M | 0.03% |
206,850
-6,600
| -3% | -$320K |
|
523
Textron
TXT
$15.3B
| $10M | 0.03% |
+277,966
| New | +$10.1M |
|
524
Arista Networks
ANET
$239B
| $10M | 0.03% |
773,600
+48,000
| +7% | +$659K |
|
|
WRK
525
DELISTED
WestRock Company
WRK
| $9.98M | 0.03% |
287,189
+4,600
| +2% | +$142K |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.